Skip to main content

Table 1 Mutation information in A. baumannii SMGC-AB2 isolated from H7N9 patient B4a

From: Clinical, immunological and bacteriological characteristics of H7N9 patients nosocomially co-infected by Acinetobacter Baumannii: a case control study

No. Gene Annotation ORF length position (NT) mutation (NT) AA length position (AA) substitute (AA)
1 putative permease, YjgP/YjgQ family protein 1101 bp 164 G → A 366 55 Arg → His
2 histidine kinase; PmrB 1335 704 C → T 444 235 Thr → Ile
3 Lipid A phosphoethanolamine transferase, associated with polymyxin resistance, PmrC 1647 1598 A → C 548 533 Lys → Thr
4 NAD-dependent aldehyde dehydrogenase 1575 421 C → T 524 141 Leu → Leu
5 Large repetitive protein, type I secretion C-terminal target domain protein 6657 547 A → G 2218 183 Val → Ile
6 Large repetitive protein, type I secretion C-terminal target domain protein 6657 874 G → A 2218 292 Val → Ile
7 Large repetitive protein, type I secretion C-terminal target domain protein 6657 876 T → C 2218 292 Val → Ile
8 Contig C497 8383 (position) C → T Non-coding region
  1. aThe reference sequence is A. baumannii SMGC-AB1 isolated from H7N9 patient B4 isolated on Day 21 after disease onset. A. baumannii SMGC-AB2 was isolated from this patient B4 on Day 26 after disease onset